Volume 12, Issue 3 (4-2014)                   IJRM 2014, 12(3): 221-0 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Molazadeh M, Karimzadeh H, Azizi M R. Prevalence and clinical significance of antinuclear antibodies in Iranian women with unexplained recurrent miscarriage. IJRM. 2014; 12 (3) :221-0
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-516-en.html
1- Department of Immunodiagnosis, Erythron Clinical Lab, Isfahan, Iran , Morteza_Molazadeh@ yahoo .com
2- Department of Rheumatology, Al-Zahra Hospital, Isfahan, Iran
3- Department of Immunology, Fertility and Infertility Center, Isfahan, Iran
Abstract:   (338 Views)
Background: Antinuclear antibodies (ANAs) in women with recurrent miscarriage have been reported. The presence of moderate to high titers of these antibodies represents an autoimmune condition that can endanger the health of the fetus in pregnant women.
Objective: In this study, we evaluated the prevalence of ANAs in Iranian women with a history of two or more unexplained abortion.
Materials and Methods: 560 women with unexplained recurrent miscarriage and 560 healthy controls accounted for this study over a period of 13 months. ANAs were detected by indirect immunofluorescence technique.
Results: ANAs were detected in 74 of 560 (13.21%) patient with recurrent miscarriage, and in only 5 of 560 (0.9%) controls (p<0.001). ANA positivity was generally found with low-positive results (1.40-1.80) in about 38% of positive cases, whereas moderate titres (1.160-1.320) and high titres (>1.640) were seen in about 46% and 16% of cases respectively. Finally evaluating of microscopic ANA patterns revealed that about half of positive cases had antibodies against DNA- histone complex, associated with systemic lupus erythematosus disease.
Conclusion: Antinuclear antibodies are not uncommon in women with unexplained recurrent miscarriage, suggesting the possible role of an autoimmune disorder on abortion, at least in a subgroup of patients.
Full-Text [PDF 271 kb]   (183 Downloads) |   |   Full-Text (HTML)  (37 Views)  
Type of Study: Original Article |

1. Regan L, Rai R. Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14: 839-854. [DOI:10.1053/beog.2000.0123]
2. Rai R, Regan L. Recurrent miscarriage. Lancet 2006; 368: 601-611. [DOI:10.1016/S0140-6736(06)69204-0]
3. Takeshita T. Diagnosis and treatment of recurrent miscarriage associated with immunologic disorders: Is paternal lymphocyte immunization a relic of the past? J Nippon Med Sch 2004; 71: 308-313. [DOI:10.1272/jnms.71.308]
4. Li Q, Li H, Tian X. [The study of autoantibodies in women with habitual abortion of unknown etiology]. Zhonghua Fu Chan Ke Za Zhi 1998; 33: 13-16. (In Chinese)
5. Bustos D, Moret A, Tambutti M, Gogorza S, Testa R, Ascione A, et al. Autoantibodies in Argentina women with recurrent pregnancy loss. Am J Reprod Immunol 2006; 55: 201-207. [DOI:10.1111/j.1600-0897.2005.00349.x]
6. Inagaki J, Kondo A, Lopez LR, Shoenfeld Y, Matsuura E. Pathogenic role of anti-laminin-1 autoantibodies. Ann N Y Acad Sci 2005; 1051: 174-184. [DOI:10.1196/annals.1361.059]
7. Shoenfeld Y, Carp HJ, Molina V, Blank M, Cervera R, Balasch J, et al. Autoantibodies and prediction of reproductive failure. Am J Reprod Immunol 2006; 56: 337-344. [DOI:10.1111/j.1600-0897.2006.00434.x]
8. Sulcebe G, Morcka K. Diagnostic and prognostic significance of different antinuclear antibodies. Clin Exp Rheumatol 1992; 10: 255-261.
9. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for Clinical Use of the Antinuclear Antibody Test and Tests for Specific Autoantibodies to Nuclear Antigens. Arch Pathol Lab Med 2000; 124: 71-81.
10. Mariz HA, Sato EI, Barbosa SH, Rodrigues SH, Dellavance A, Andrade LE. Pattern on the antinuclear antibody-Hep-2 test is a critical parameter for discriminating 119 antinuclear anti-body positive healthy individuals and patients with autoimmune rheumatic 120 diseases. Arthritis Rheum 2011; 63: 191-200. [DOI:10.1002/art.30084]
11. Malinowski A, Szpakowski M, Wilczyński J, Oszukowski P, Puchała B, Włodarczyk B. Antinuclear antibodies in women with recurrent pregnancy wastage and their prognostic value for immunotherapy. Zentrabl Gynakol 1994; 116: 631-635.
12. Gleicher N. Autoantibodies in infertility: Curent opinion. Hum Reprod Update 1998; 4: 169-176. [DOI:10.1093/humupd/4.2.169]
13. Walia GK, Mukhopadhyay R, Saraswathy KN, Puri M, Chahal SMS. Immuno-Molecular Etiology of Recurrent Pregnancy Loss and the Anthropological Perspective. Int J Hum Genet 2008; 8: 227-235. [DOI:10.1080/09723757.2008.11886033]
14. Kutteh WH, Odom LN. Evaluating recurrent pregnancy loss: The role of autoimmune screening. SRM J 2012; 10: 5-11.
15. Cubillos J, Lucena A, Lucena C, Mendoza JC, Ruiz H, Arango A, et al. Incidence of autoantibodies in the infertile population. Early Pregnancy 1997; 3: 119-124.
16. Shoenfeld Y, Carp HJ, Molina V, Blank M, Cervera R, Balasch J, et al. Autoantibodies and prediction of reproductive failure. Am J Reprod Immonol 2006; 56: 337-344. [DOI:10.1111/j.1600-0897.2006.00434.x]
17. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40: 1601-1611. [DOI:10.1002/art.1780400909]
18. Slater CA, Davis RB, Shmerling RH. Antinuclear antibody testing: a study of clinical utility. Arch Intern Med 1996; 156: 1421-1425. [DOI:10.1001/archinte.1996.00440120079007]

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb